| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |